tBid and PEF preserve the integrity of the mitochondrial matrix compartment, as measured by retention of a soluble mitochondrial matrix protein, mtHsp70. (A) mtHsp70 is released when mitochondria are treated with intermediate concentrations of digitonin. Xenopus egg mitochondria were treated with increasing concentrations of digitonin to selectively permeabilize the outer, then the inner mitochondrial membranes. After two hours incubation, the contents of the pellet and supernatant fractions were analyzed by immunoblotting (left panel) with antibodies to cytochrome c, mtHsp70, and the inner membrane-associated Rieske protein (part of complex III). Also, accessibility of complex IV was measured as described above (right panel). Note that mtHsp70 is released by digitonin at 0.2%, a concentration insufficient to solubilize the Rieske protein, but more than sufficient to release cytochrome c. (B) mtHsp70 is not released by tBid and PEF, despite full release of cytochrome c and full accessibility of complex IV. Xenopus mitochondria were treated with 170 ng/ml tBid, in either the presence or absence of cytosol, and either at 0 or 22°C, as indicated. DEVD-CHO (10 μM) was added to cytosol incubations to minimize PEF degradation and thus maximize its activity. After 3 h of incubation, the contents of the mitochondrial pellet were analyzed by immunoblotting with antibodies to cytochrome c, mtHsp70 and Rieske protein (left), and the accessibility of complex IV (right). The samples were taken well after full cytochrome c release from mitochondria, which occurred in this experiment at 1 h in the tBid-treated sample and at 2 h in cytosol at 22°C (not shown). Note that mtHsp70 is retained in the pellet fraction despite full cytochrome c release and increased complex IV accessibility (reflecting PEF activity). (The bands stained by anti-Rieske antibody in cytosol are nonmitochondrial cross-reacting proteins.)